A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?

References

• NotarangeloLCasanovaJLConleyMEPrimary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005J Allergy Clin Immunol2006117488389616680902
   PubMed Web of Science ®Google Scholar
• Al-HerzWBousfihaACasanovaJLPrimary immunodeficiency diseases; an update on the classification from the international union of immunological societies expert committee for primary immunodeficiencyFront Immunol2014516224795713
   PubMed Web of Science ®Google Scholar
• PicardCAl-HerzWBousfihaAPrimary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015J Clin Immunol201535869672626482257
   PubMed Web of Science ®Google Scholar
• GathmannBBinderNEhlSKindleGThe European Internet-based patient and research database for primary immunodeficiencies: update 2011Clin Exp Immunol20111673479491 retracted
   Web of Science ®Google Scholar
• ChampiCPrimary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatmentJ Pediatr Health Care2002161162111802116
   PubMedGoogle Scholar
• GardulfAImmunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous routeBioDrugs200721210511617402794
   PubMed Web of Science ®Google Scholar
• NegiVSElluruSSibérilSIntravenous immunoglobulin: an update on the clinical use and mechanisms of actionJ Clin Immunol200727323324517351760
   PubMed Web of Science ®Google Scholar
• NicolayUKiesslingPBergerMHealth-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency [sic] diseases receiving subcutaneous IgG self-infusions at homeJ Clin Immunol2006261657216418804
   PubMed Web of Science ®Google Scholar
• GardulfANicolayUReplacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficienciesCurr Opin Allergy Clin Immunol20066643444217088648
   PubMed Web of Science ®Google Scholar
• MisbahSSturzeneggerMHBorteMSubcutaneous immunoglobulin: opportunities and outlookClin Exp Immunol2009158Suppl 1515919883424
   PubMed Web of Science ®Google Scholar
• WoodPHuman normal immunoglobulin in the treatment of primary immunodeficiency diseasesTher Clin Risk Manag2012815716722547934
   PubMed Web of Science ®Google Scholar
• BeautéJLevyPMilletVEconomic evaluation of immunoglobulin replacement in patients with primary antibody deficienciesClin Exp Immunol2009160224024520041884
   PubMed Web of Science ®Google Scholar
• WoodPStanworthSBurtonJRecognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic reviewClin Exp Immunol2007149341042317565605
   PubMed Web of Science ®Google Scholar
• KobrynskiLSubcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseasesBiologics2012627728722956859
   PubMedGoogle Scholar
• KerrJQuintiIEiblMIs dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in EuropeFront Immunol2014562925566244
   PubMed Web of Science ®Google Scholar
• QuartierPDebréMDe BlicJEarly and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patientsJ Pediatr1999134558959610228295
   PubMed Web of Science ®Google Scholar
• RoifmanCMSchroederHBergerMComparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency: a randomized double-blind trialInt Immunopharmacol2003391325133312890430
   PubMed Web of Science ®Google Scholar
• SriaroonPBallowMImmunoglobulin replacement therapy for primary immunodeficiencyImmunol Allergy Clin North Am201535471373026454315
   PubMed Web of Science ®Google Scholar
• AguilarCMalphettesMDonadieuJPrevention of infections during primary immunodeficiencyClin Infect Dis201459101462147025124061
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyGuideline on core SmPC for human normal immunoglobulin for subcutaneous and intramuscular administration2015 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/03/WC500184870.pdfAccessed May 1, 2017
   Google Scholar
• Association IRISEnquête sur le traitement substitutif en immunoglobulines auprès de patients atteints de deficits immunitaires primitifs2006 Available from: http://docplayer.fr/12693266-Enquete-surle-traitement-substitutif-en-immunoglobulines-aupres-de-patientsatteints-de-deficits-immunitaires-primitifs.htmlAccessed May 1, 2017
   Google Scholar
• GardulfANicolayUAsensioORapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies: a prospective, multi-national studyJ Clin Immunol200626217718516758340
   PubMed Web of Science ®Google Scholar
• ChapelHMSpickettGPEricsonDEnglWEiblMMBjorkanderJThe comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapyJ Clin Immunol20002029410010821460
   PubMed Web of Science ®Google Scholar
• FasthANyströmJSafety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiencyActa Paediatr200796101474147817850391
   PubMed Web of Science ®Google Scholar
• WassermanRLHizentra for the treatment of primary immunodeficiencyExpert Rev Clin Immunol201410101293130725182658
   PubMed Web of Science ®Google Scholar
• Lingman-FrammeJFasthASubcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based reviewDrugs201373121307131923861187
   PubMed Web of Science ®Google Scholar
• GardulfAHammarströmLSmithCIHome treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusionLancet199133887601621661712881
   PubMed Web of Science ®Google Scholar
• WaniewskiJGardulfAHammarströmLBioavailability of γ-globulin after subcutaneous infusions in patients with common variable immunodeficiencyJ Clin Immunol199414290977515071
   PubMed Web of Science ®Google Scholar
• BergerMSubcutaneous immunoglobulin replacement in primary immunodeficienciesClin Immunol200411211715207776
   PubMed Web of Science ®Google Scholar
• ThomasMJBrennanVMChapelHHRapid subcutaneous immunoglobulin infusions in childrenLancet1993342888414321433
   Web of Science ®Google Scholar
• AbrahamsenTGSandersenHBustnesAHome therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficienciesPediatrics1996986 Pt 1112711318951264
   PubMed Web of Science ®Google Scholar
• GasparJGerritsenBJonesAImmunoglobulin replacement treatment by rapid subcutaneous infusionArch Dis Child199879148519771252
   PubMed Web of Science ®Google Scholar
• CherinPMarieIMichalletMManagement of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidenceAutoimmun Rev2016151718126384525
   PubMed Web of Science ®Google Scholar
• OchsHDGuptaSKiesslingPNicolayUBergerMSafety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseasesJ Clin Immunol200626326527316783465
   PubMed Web of Science ®Google Scholar
• DalyPBEvansJHKobayashiRHHome-based immunoglobulin infusion therapy: quality of life and patient health perceptionsAnn Allergy19916755045101958004
   PubMedGoogle Scholar
• HoffmannFGrimbacherBThielJPeterHHBelohradskyBHHome-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiencyEur J Med Res201015623824520696632
   PubMed Web of Science ®Google Scholar
• KuburovicNBPasicSSusicGHealth-related quality of life, anxiety, and depressive symptoms in children with primary immuno-deficienciesPatient Prefer Adherence2014832333024669189
   PubMed Web of Science ®Google Scholar
• SoresinaANacinovichRBombaMThe quality of life of children and adolescents with X-linked agammaglobulinemiaJ Clin Immunol200929450150719089603
   PubMed Web of Science ®Google Scholar
• ZebrackiKPalermoTMHostofferRDuffKDrotarDHealth-related quality of life of children with primary immunodeficiency disease: a comparison studyAnn Allergy Asthma Immunol200493655756115609765
   PubMed Web of Science ®Google Scholar
• TitmanPAllwoodZGilmourCQuality of life in children with primary antibody deficiencyJ Clin Immunol201434784485225005831
   PubMed Web of Science ®Google Scholar
• HealthActCHQ IncChild Health Questionnaire Scoring and Interpretation Manual2008HealthActCHQ IncCambridge MA USA
   Google Scholar
• NicolayUHaagSEichmannFHergetSSpruckDGardulfAMeasuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapyQual Life Res20051471683169116119180
   PubMed Web of Science ®Google Scholar
• JiangFTorgersonTRAyarsAGHealth-related quality of life in patients with primary immunodeficiency diseaseAllergy Asthma Clin Immunol2015112726421019
   PubMed Web of Science ®Google Scholar
• GardulfANicolayUMathDChildren and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at homeJ Allergy Clin Immunol2004114493694215480339
   PubMed Web of Science ®Google Scholar
• BergerMMurphyERileyPBergmanGEImproved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin GSouth Med J2010103985686320689467
   PubMed Web of Science ®Google Scholar
• VultaggioAAzzariCMilitoCSubcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter studyClin Drug Investig2015353179185
   PubMed Web of Science ®Google Scholar
• AbolhassaniHSadaghianiMSAghamohammadiAOchsHDRezaeiNHome-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysisJ Clin Immunol20123261180119222730009
   PubMed Web of Science ®Google Scholar
• BienvenuBCozonGHoarauCDoes the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort “Visages”Orphanet Journal of Rare Diseases20161118327334100
   PubMed Web of Science ®Google Scholar
• Skoda-SmithSTorgersonTROchsHDSubcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency diseaseTher Clin Risk Manag2010611020169031
   PubMed Web of Science ®Google Scholar
• BergerMPrinciples of and advances in immunoglobulin replacement therapy for primary immunodeficiencyImmunol Allergy Clin North Am2008282413437x18424340
   PubMed Web of Science ®Google Scholar
• KittnerJMGrimbacherBWulffWJägerBSchmidtREPatients’ attitude to subcutaneous immunoglobulin substitution as home therapyJ Clin Immunol200626440040516783533
   PubMed Web of Science ®Google Scholar
• DamsETvan der MeerJWSubcutaneous immunoglobulin replacement in patients with primary antibody deficienciesLancet19953458953864
   Web of Science ®Google Scholar